Aldosterone's mechanism of action: Roles of lysine-specific demethylase 1, caveolin and striatin

Current Opinion in Nephrology and Hypertension

Volumn 23, Issue 1, 2014, Pages 32-37

  Baudrand, Rene ^a,b   Pojoga, Luminita H ^a   Romero, Jose R ^a   Williams, Gordon H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

aldosterone; caveolin 1; lysine specific demethylase 1; mineralocorticoid receptor striatin

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; CAVEOLIN; CELL NUCLEUS RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPITHELIAL SODIUM CHANNEL; ESTROGEN RECEPTOR ALPHA; G PROTEIN COUPLED RECEPTOR; LYSINE SPECIFIC DEMETHYLASE 1; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROGESTERONE; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAFFOLD PROTEIN; STRIATIN; UNCLASSIFIED DRUG;

CAVEOLA; CHROMATIN STRUCTURE; DNA METHYLATION; DNA SEQUENCE; ESSENTIAL HYPERTENSION; GENE CONTROL; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HEART RIGHT VENTRICLE DYSPLASIA; HISTONE ACETYLATION; HISTONE MODIFICATION; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA VOLUME; PRIORITY JOURNAL; PROMOTER REGION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT LOADING; SALT SENSITIVE HYPERTENSION; SIGNAL TRANSDUCTION; SODIUM INTAKE; SODIUM RETENTION; SODIUM URINE LEVEL;

ALDOSTERONE; ANIMALS; CALMODULIN-BINDING PROTEINS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CAVEOLINS; EPIGENOMICS; HEMODYNAMICS; HISTONE DEMETHYLASES; HUMANS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION; SODIUM CHLORIDE, DIETARY;

EID: 84890548131     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/01.mnh.0000436543.48391.e0     Document Type: Review

References (42)

1. & Simino J, Rao DC, Freedman BI. Novel findings and future directions on the genetics of hypertension. Curr Opin Nephrol Hypertens 2012; 21:500-507. An outstanding review of the future directions of genetic studies in hypertension.
2. Cowley AW Jr, Nadeau JH, Baccarelli A, et al. Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension 2012; 59:899-905.
3. Millis RM. Epigenetics and hypertension. Curr Hypertens Rep 2011; 13: 21-28.
4. Zhang LN, Liu PP, Wang L, et al. Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension. PLoS One 2013; 8:e63455. A key study demonstrating epigenetic changes in promoter DNA methylation of a-adducin (ADD1) gene in the pathogenesis of essential hypertension.
5. Grant FD, Romero JR, Jeunemaitre X, et al. Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism. Hypertension 2002; 39:191-196.
6. Liu K, Liu J, Huang Y, et al. Alpha-adducin Gly460Trp polymorphism and hypertension risk: A meta-analysis of 22 studies including 14303 cases and 15961 controls. PLoS One 2010; 5:e13057.
7. Li YY. alpha-Adducin Gly460Trp gene mutation and essential hypertension in a Chinese population: A meta-analysis including 10,960 subjects. PLoS One 2012; 7:e30214.
8. Ding Y, Lv J, Mao C, et al. High-salt diet during pregnancy and angiotensinrelated cardiac changes. J Hypertens 2010; 28:1290-1297.
9. Xu X, Su S, Barnes VA, et al. A genome-wide methylation study on obesity: Differential variability and differential methylation. Epigenetics 2013; 8:522-533.
10. Ronn T, Volkov P, Davegardh C, et al. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet 2013; 9:e1003572.
11. Williams GH, Hollenberg NK. Sodium-sensitive essential hypertension: Emerging insights into an old entity. J Am Coll Nutr 1989; 8:490-494.
12. Chamarthi B, Williams JS, Williams GH. A mechanism for salt-sensitive hypertension: Abnormal dietary sodium-mediated vascular response to angiotensin-II. J Hypertens 2010; 28:1020-1026.
13. El Shamieh S, Visvikis-Siest S. Genetic biomarkers of hypertension and future challenges integrating epigenomics. Clin Chim Acta 2012; 414:259-265.
14. Pojoga LH, Williams JS, Yao TM, et al. Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension. Am J Physiol Heart Circ Physiol 2011; 301:H1862-H1871.
15. Williams JS, Chamarthi B, Goodarzi MO, et al. Lysine-specific demethylase 1: An epigenetic regulator of salt-sensitive hypertension. Am J Hypertens 2012; 25:812-817. A seminal translational study describing the role of LSD-1 as a crucial epigenetic regulator of salt sensitivity of BP in both human and rodents.
16. Shi Y. Histone lysine demethylases: Emerging roles in development, physiology and disease. Nat Rev Genet 2007; 8:829-833.
17. Krug AW, Tille E, Sun B, et al. Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake. Age (Dordr) 2013; 35:1809-1820. An interesting study that highlights the important interaction between ageing, epigenetic changes and environment.
18. Mu S, Shimosawa T, Ogura S, et al. Epigenetic modulation of the renal betaadrenergic-WNK4 pathway in salt-sensitive hypertension. Nat Med 2011; 17:573-580.
19. Krug AW, Pojoga LH, Williams GH, Adler GK. Cell membrane-associated mineralocorticoid receptors New evidence. Hypertension 2011; 57:1019-1025.
20. Ricchiuti V, Lapointe N, Pojoga L, et al. Dietary sodium intake regulates angiotensin II type 1, mineralocorticoid receptor, and associated signaling proteins in heart. J Endocrinol 2011; 211:47-54.
21. Gildea JJ, Kemp BA, Howell NL, et al. Inhibition of renal caveolin-1 reduces natriuresis and produces hypertension in sodium-loaded rats. Am J Physiol Renal Physiol 2011; 300:F914-F920.
22. Pojoga LH, Adamova Z, Kumar A, et al. Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol 2010; 298: H1776-H1788.
23. Pojoga LH, Romero JR, Yao TM, et al. Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II. Endocrinology 2010; 151:1236-1246.
24. Pojoga LH, Yao TM, Sinha S, et al. Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol 2008; 294:H1258-H1265.
25. Nakamura T, Fukuda M, Kataoka K, et al. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats. Hypertens Res 2011; 34:817-824.
26. Sowa G. Caveolae, caveolins, cavins, and endothelial cell function: New insights. Front Physiol 2012; 2:120.
27. van Dokkum RP, Buikema H. Possible new druggable targets for the treatment of nephrosis. Perhaps we should find them in caveolae Curr Opin Pharmacol 2009; 9:132-138.
28. Fujita T. Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 2010; 55:813-818.
29. Shibata S, Nagase M, Yoshida S, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: Implication in proteinuric kidney disease. Nat Med 2008; 14:1370-1376.
30. Nethe M, Anthony EC, Fernandez-Borja M, et al. Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway. J Cell Sci 2010; 123:1948-1958.
31. Lee IH, Campbell CR, Song SH, et al. The activity of the epithelial sodium channels is regulated by caveolin-1 via a Nedd4-2-dependent mechanism. J Biol Chem 2009; 284:12663-12669.
32. Li X, McClellan ME, Tanito M, et al. Loss of caveolin-1 impairs retinal function due to disturbance of subretinal microenvironment. J Biol Chem 2012; 287:16424-16434.
33. Morrill GA, Kostellow AB, Askari A. Caveolin-Na/K-ATPase interactions: Role of transmembrane topology in nongenomic steroid signal transduction. Steroids 2012; 77:1160-1168.
34. Park JH, Ryu JM, Yun SP, et al. Fibronectin stimulates migration through lipid raft dependent NHE-1 activation in mouse embryonic stem cells: Involvement of RhoA, Ca(2)/CaM, and ERK. Biochim Biophys Acta 2012; 1820:1618-1627.
35. Ares GR, Ortiz PA. Dynamin2, clathrin, and lipid rafts mediate endocytosis of the apical Na/K/2Cl cotransporter NKCC2 in thick ascending limbs. J Biol Chem 2012; 287:37824-37834. A key study documenting that cav-1 silencing by shRNA in the rat kidney decreases the rate of NKCC2 endocytosis, consistent with a key role for cav-1 in renal sodium handling.
36. Tajima N, Itokazu Y, Korpi ER, et al. Activity of BK(Ca) channel is modulated by membrane cholesterol content and association with Na/K-ATPase in human melanoma IGR39 cells. J Biol Chem 2011; 286:5624-5638.
37. Gordon J, Hwang J, Carrier KJ, et al. Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste20-Like kinase Mst3. BMC Biochem 2011; 12:54.
38. Lu Q, Pallas DC, Surks HK, et al. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci U S A 2004; 101:17126-17131.
39. Bernelot Moens SJ, Schnitzler GR, Nickerson M, et al. Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury. Circulation 2012; 126:1993-2004. Using a novel mouse model, these investigators documented the effect on vascular injury in an in-vivo study when the interaction between striatin and oestrogen receptor-a is blocked.
40. Pojoga LH, Coutinho P, Rivera A, et al. Activation of the mineralocorticoid receptor increases striatin levels. Am J Hypertens 2012; 25:243-249. A key study providing evidence that mineralocorticoid receptor activation leads to increases in the scaffolding protein striatin, both in vivo and in vitro.
41. Yanai I, Benjamin H, Shmoish M, et al. Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics 2005; 21:650-659.
42. Meurs KM, Mauceli E, Lahmers S, et al. Genome-wide association identifies a deletion in the 3' untranslated region of striatin in a canine model of arrhythmogenic right ventricular cardiomyopathy. Hum Genet 2010; 128: 315-324.